Levagen®+ logo with blue and light blue dots around the brand name.

Power Up Dispersion

Levagen®+ is a cold water dispersible palmitoylethanolamide (PEA). Utilising patented LipiSperse® delivery system technology it is specifically formulated to overcome the traditional dispersion issues of PEA.

Award-winning LipiSperse® is scientifically proven to increase bioavailability and functionality of PEA. Levagen®+ has been shown to be absorbed within 45 minutes, with x1.75 the absorption than standard PEA.

PEA influences the endocannabinoid system, and thereby is considered a safe and clinically-proven alternative to CBD.

Levagen®+ advantages

  • superior bioavailability to standard PEA

  • safe alternative to CBD

  • convenient format options

  • clinically studied and proven

  • non-GMO, gluten free, allergen free

  • Gencor self-affirmed GRAS

  • Informed-Ingredient Certified by LGC-to be WADA-banned substances free

  • multi award winning

  • utilising patent LipiSperse® technology

  • Australian made

Two laboratory beakers containing different solutions, with the left beaker holding a clear solution and a small floating object, and the right beaker containing a cloudy, white substance.
Person sitting at a desk with hands behind head, facing a computer monitor, with a potted green plant and a vintage camera on the desk, and a tall floor lamp nearby.

Cognitive Function

This study assessed the effects of PEA on serum BDNF levels and parameters of cognitive function in healthy adults.

Person sitting on the floor with one knee up, wearing ripped blue jeans and a loose cream sweater, holding their ankle with both hands.

Peripheral Neuropathic Pain

This study evaluated the safety, tolerability and efficacy of Levagen®+ in treating diabetic-related peripheral neuropathic pain (PNP).

mid- thigh pull

Muscle Strength and Exercise Performance

The aim of this study was to investigate the effects of daily PEA supplementation combined with 8‐weeks of resistance training on lean body mass.

Migraine suffering

Migraine

Headaches typically can last between 2 to 24 hours, with most migraine headaches lasting about 4 hours. The study explored PEA as a safe and effective alternative in reducing pain and duration.

allergic responses

Allergic Rhinitis

AR is an inflammatory, symptomatic disorder that is stimulated by allergens. This study evaluated the efficacy of PEA, as an alternative treatment for these symptoms.

A man holding eyeglasses while covering his face with his other hand.

Alternative to Ibuprofen

This study assessed the efficacy of Levagen®+ for reducing the severity and duration of acute episodes of tension-type headaches when compared to treatment with ibuprofen.

Illustration of virus particles with a round shape, colorful spikes, and textured surface against a blurred background.

Inflammation responses post Covid-19

This study examined the effects of PEA on pro-inflammatory biomarkers in adults recently diagnosed with COVID-19 who were unvaccinated and non hospitalized.

Person sitting on a bed holding their lower back in pain, wearing a white sleeveless top and denim shorts. The bed has white sheets and a brown headboard.

Joint Pain

This study aimed to assess the efficacy of PEA, for alleviating joint pain and improving quality of life.

A woman with long brown hair lying face down on a white bed, wearing a gray t-shirt, with one hand resting near her face and the other extended outward.

Sleep Disturbance

This study aimed to asses the efficacy of PEA supplementation on sleep quality in adults with sleep pattern disturbance.

A person applying lotion to their thigh indoors, holding a blue and white container labeled 'Batch' with sunlight casting shadows.

Knee osteoarthritis pain and other symptoms

The study was to assess the safety, tolerability and efficacy of PEA when dosed at 300mg and 600mg per day on symptoms of knee osteoarthritis.

Logo for the European Specialist Sports Nutrition Awards 2023 featuring a stylized figure with a yellow crescent and gray circle, and text highlighting 5 years of excellence.
A person wearing red athletic wear is wrapping their hands with boxing hand wraps.

Muscle recovery

The study aimed to compare the bioavailability of a single dose of Levagen®+ (PEA + LipiSperse®) in an Exercise Study, demonstrating Levagen®+ aids in muscle recovery.

Bar chart displaying the total activity area under curve (AUC) from 0-6 hours for PEA standard powder and PEA CWD 90 with LipiSPerse®. The PEA CWD 90 with LipiSPerse® shows a higher AUC than the PEA standard powder, with the former approaching 280 and the latter around 150.

Increased absorption of PEA using LipiSperse®

LipiSperse® dispersion technology as Levagen®+ (PEA) has been used in a pharmacokinetic study to evaluate the absorption of palmitoylethanolamide.

  • Best Sports Nutrition Ingredient of the Year

  • Most Exciting Partnership - Gencor & Gloucester Rugby Levagen®+ and HydroCurc®

Logo for the Winner Nutra Ingredients Awards 2021 with a stylized leaf icon in orange, blue, and yellow.

  • Ingredient of the Year Healthy Ageing - USA

  • Research Project of the Year - Asia

Levagen is a registered trademark of Gencor Pacific Ltd

LipiSperse is a patented technology and trademark owned exclusively by Pharmako Biotechnologies Pty.Ltd., registered in Australia and other countries.